Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

AAlkermes plc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
A

Alkermes plc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

SellBuy
DateNameTitleSharesValueTransactionSource
Oct 2, 2026Gaffin David JosephEVP, CLO, Alkermes, Inc.2,034Ordinary Shares$84.9KSell
Sep 3, 2026Gaffin David JosephEVP, CLO, Alkermes, Inc.2,034Ordinary Shares$96.4KSell
Sep 1, 2026Hopkinson Craig C.EVP R&D, Chief Medical Officer9,000Ordinary Shares$426.7KSell
Sep 1, 2026Hopkinson Craig C.EVP R&D, Chief Medical Officer5,000Ordinary Shares$237.1KOption exercise
Aug 17, 2026Nichols Christian ToddSVP, Chief Commercial Officer7,576Ordinary Shares$371.7KSell
Aug 5, 2026Jackson Blair CurtisPresident & CEO, Alkermes plc217,534Employee Stock Option (Right to Buy)$10.7MGrant / award
Aug 3, 2026Gaffin David JosephEVP, CLO, Alkermes, Inc.2,034Ordinary Shares$99.6KSell
Aug 3, 2026Hopkinson Craig C.EVP R&D, Chief Medical Officer9,000Ordinary Shares$440.9KSell
Aug 3, 2026Hopkinson Craig C.EVP R&D, Chief Medical Officer5,000Ordinary Shares$245KOption exercise
Aug 3, 2026snyderman nancy lynn MDDirector44,472Ordinary Shares$2.2MSell
…
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • Insider Transactions
$41.65Close · Oct 6, 2026